Slide 1Induction Therapy For Multiple Myeloma: Two vs Three Drug Regimen and Role of Risk Stratification Ravi Vij MD Associate Professor Section of BMT and Leukemia Washington…
* ANCO ASH Highlights 2007: Multiple Myeloma Joseph M. Tuscano, MD University of California, Davis * Abstracts [73] Bortezomib (Velcade )-Thalidomide-Dexamethasone (VTD)…